Ligand ID: TE4 Drugbank ID: DB09085(Tetracaine) Indication:The combination lidocaine and tetracaine patch is indicated for local dermal analgesia for superficial dermatological procedures and superficial venous access. The combination lidocaine and tetracaine cream is intended to provide topical local analgesia for superficial dermatological procedures. |
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
View | Interface | RMSD | Seq. Identity (%) |
HETATM | Dock | |
---|---|---|---|---|---|---|---|---|---|---|
![]() | 4Y0P_A_TE4A201_1 (BETA-LACTOGLOBULIN) | 1zv8 | E2 GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | VAL B 22LEU D 19ILE C 16ILE E 16LEU C 27 | 1.21A | 20.61 | None | ||
![]() | 4OMW_D_TE4D202_1 (BETA-LACTOGLOBULIN) | 2acf | REPLICASEPOLYPROTEIN 1AB (SARS-COVTor2) | 5 / 9 | LEU A 309PRO A 307ASN A 281ALA A 284SER A 310 | 1.80A | 24.87 | None | ||
![]() | 4Y0P_A_TE4A201_1 (BETA-LACTOGLOBULIN) | 2ahm | REPLICASEPOLYPROTEIN 1AB,HEAVY CHAINREPLICASEPOLYPROTEIN 1AB,LIGHT CHAIN (SARSr-CoV) | 5 / 12 | LEU G 96ILE G 112ILE C 73VAL C 71LEU C 22 | 1.16A | 20.37 | None | ||
![]() | 4Y0P_A_TE4A201_1 (BETA-LACTOGLOBULIN) | 2ajf | ACE2 (Homosapiens) | 5 / 12 | LEU B 570VAL B 573LEU B 410ILE B 407LEU B 539 | 1.20A | 14.57 | None | ||
![]() | 4Y0P_A_TE4A201_1 (BETA-LACTOGLOBULIN) | 2beq | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | VAL D1171LEU E1168ILE B 916ILE C 916LEU B 927 | 1.28A | 17.90 | NoneNoneACE B 913 ( 3.9A)ACE C 913 ( 4.1A)None | ||
![]() | 4OMW_D_TE4D202_1 (BETA-LACTOGLOBULIN) | 2fav | REPLICASEPOLYPROTEIN 1AB(PP1AB) (ORF1AB) (SARSr-CoV) | 5 / 9 | LEU C 128PRO C 126ASN C 100ALA C 103SER C 129 | 1.74A | 26.13 | None | ||
![]() | 4Y0P_A_TE4A201_1 (BETA-LACTOGLOBULIN) | 2gdt | NSP1 (EC 3.4.22.-) P65 HOMOLOGLEADER PROTEIN (SARSr) | 5 / 12 | LEU A 35LEU A 45ILE A 60VAL A 12LEU A 53 | 1.19A | 28.12 | None | ||
![]() | 4Y0P_A_TE4A201_1 (BETA-LACTOGLOBULIN) | 2gri | NSP3 (SARSr) | 5 / 12 | LEU A 66LEU A 90ILE A 24VAL A 58PHE A 88 | 1.28A | 22.78 | None | ||
![]() | 4Y0P_A_TE4A201_1 (BETA-LACTOGLOBULIN) | 2og3 | NUCLEOCAPSID PROTEIN (SARS-COVTor2) | 5 / 12 | LEU A 114LEU A 65ILE A 131LEU A 160PHE A 111 | 1.29A | 23.21 | None | ||
![]() | 4Y0P_A_TE4A201_1 (BETA-LACTOGLOBULIN) | 2ozk | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARSr-CoV) | 5 / 12 | LEU D 331VAL D 318ILE D 327ILE D 322ILE D 295 | 1.20A | 18.66 | None | ||
![]() | 4Y0P_A_TE4A201_1 (BETA-LACTOGLOBULIN) | 2xyr | PUTATIVE 2'-O-METHYLTRANSFERASE (SARSr-CoV) | 5 / 12 | LEU A 163ILE A 167LYS A 123ILE A 157LEU A 57 | 1.33A | 20.66 | None | ||
![]() | 4OMW_D_TE4D202_1 (BETA-LACTOGLOBULIN) | 3d0g | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 5 / 9 | LEU B 100ALA B 71GLU B 75GLN B 76SER B 77 | 1.64A | 16.15 | None | ||
![]() | 4Y0P_A_TE4A201_1 (BETA-LACTOGLOBULIN) | 3d0h | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 5 / 12 | LEU A 570VAL A 573LEU A 410ILE A 407LEU A 539 | 1.17A | 14.36 | None | ||
![]() | 4Y0P_A_TE4A201_1 (BETA-LACTOGLOBULIN) | 3scj | ACE2 (Homosapiens) | 5 / 12 | LEU A 570VAL A 573LEU A 410ILE A 407LEU A 539 | 1.09A | 14.59 | None | ||
![]() | 4OMW_D_TE4D202_1 (BETA-LACTOGLOBULIN) | 3scl | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 5 / 9 | LEU A 100ALA A 71GLU A 75GLN A 76SER A 77 | 1.67A | 15.09 | None | ||
![]() | 4Y0P_A_TE4A201_1 (BETA-LACTOGLOBULIN) | 3scl | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 5 / 12 | LEU A 570VAL A 573LEU A 410ILE A 407LEU A 539 | 1.24A | 14.72 | None | ||
![]() | 4Y0P_A_TE4A201_1 (BETA-LACTOGLOBULIN) | 5f22 | NSP8NSP7 (SARSr-CoV) | 5 / 12 | LEU B 96ILE B 112ILE A 73VAL A 71LEU A 22 | 1.26A | 22.49 | None | ||
![]() | 4Y0P_A_TE4A201_1 (BETA-LACTOGLOBULIN) | 5x29 | ENVELOPE SMALLMEMBRANE PROTEIN (SARSr-CoV) | 5 / 12 | LEU A 34ILE A 33ILE B 33VAL B 29LEU A 27 | 1.33A | 19.72 | None | ||
![]() | 4Y0P_A_TE4A201_1 (BETA-LACTOGLOBULIN) | 5x58 | SPIKE GLYCOPROTEIN (SARS-COVBJ01) | 5 / 12 | VAL B 860LEU B 920ILE B 800ILE B 704VAL B 708 | 1.17A | 8.77 | None | ||
![]() | 4Y0P_A_TE4A201_1 (BETA-LACTOGLOBULIN) | 5xlr | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | VAL A 860LEU A 920ILE A 800ILE A 704VAL A 708 | 1.29A | 8.51 | VAL A 860 ( 0.6A)LEU A 920 ( 0.6A)ILE A 800 ( 0.7A)ILE A 704 ( 0.7A)VAL A 708 ( 0.6A) | ||
![]() | 4Y0P_A_TE4A201_1 (BETA-LACTOGLOBULIN) | 6acc | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | VAL B 860LEU B 920ILE B 800ILE B 704VAL B 708 | 1.25A | 8.51 | None | ||
![]() | 4Y0P_A_TE4A201_1 (BETA-LACTOGLOBULIN) | 6crv | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | VAL B 124ILE B 115ILE B 152ILE B 234LEU B 194 | 1.27A | 8.60 | None | ||
![]() | 4Y0P_A_TE4A201_1 (BETA-LACTOGLOBULIN) | 6cs1 | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | VAL A 860LEU A 920ILE A 800ILE A 704VAL A 708 | 1.22A | 9.09 | None | ||
![]() | 4Y0P_A_TE4A201_1 (BETA-LACTOGLOBULIN) | 6jyt | HELICASE (SARSr-CoV) | 5 / 12 | LEU A 219VAL A 154LEU A 227LEU A 176PHE A 200 | 1.28A | 14.44 | None | ||
![]() | 4Y0P_A_TE4A201_1 (BETA-LACTOGLOBULIN) | 6m17 | SODIUM-DEPENDENTNEUTRAL AMINO ACIDTRANSPORTER B(0)AT1 (Homosapiens) | 5 / 12 | LEU A 415LEU A 427ILE A 422VAL A 233PHE A 237 | 1.27A | 13.33 | None | ||
![]() | 4Y0P_A_TE4A201_1 (BETA-LACTOGLOBULIN) | 6m18 | ACE2 (Homosapiens) | 5 / 12 | LEU B 570VAL B 573LEU B 410ILE B 407LEU B 539 | 1.21A | 11.90 | None | ||
![]() | 4OMW_D_TE4D202_1 (BETA-LACTOGLOBULIN) | 6m1d | ACE2 (Homosapiens) | 5 / 9 | LEU B 100ASN B 103ALA B 71GLN B 76SER B 77 | 1.67A | 12.67 | None | ||
![]() | 4OMW_D_TE4D202_1 (BETA-LACTOGLOBULIN) | 6nur | NSP12 (SARSr-CoV) | 5 / 9 | LEU A 708ASN A 781ASN A 703ALA A 699GLN A 468 | 1.75A | 9.95 | None |